After a series of restrictions placed on AstraZeneca’s vaccine and while Johnson & Johnson is equally in turmoil, the European Commission appears to want to take the lead this time: the President of the institution, Ursula von der Leyen, announced on Wednesday 14 April that a new agreement had been reached with the Pfizer/BioNTech group for 50 million additional doses. A third contract is also reportedly in the process of being negotiated.
The 50 million doses that have been announced...